Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BST/NBYB stock hub

BST/NBYB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BST/NBYBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

325.4M

Stuttgart Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BST/NBYB

In the news

Latest news · BST/NBYB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-1,310

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BST/NBYB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

USD

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	105
Employees Change	0%
Employees Change Percent	0
Enterprise value	EUR 388.7M
Exchange	Stuttgart Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 325.4M
Price	EUR 0.18
Price currency	EUR
Rev Per Employee	11,177.55x
Sic	2836
Symbol	bst/NBYB
Website	https://www.nwbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.09%
EV Earnings	-7.42x
EV/FCF	-9.86x
FCF yield	-12.11%
P/B ratio	-8.03x
P/S ratio	277.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -23.3M
Net Income	EUR -52.4M
Pretax Margin	-4,404.86%
Profit Per Employee	EUR -498,666
ROA	-69.33
Roa5y	-109.3
ROCE	575.5
ROIC	-1,310

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-26.84%
Cagr3y	-28.67%
Cagr5y	-31.58%
Revenue Growth	-0.29x
Revenue Growth Q	190.91x
Revenue Growth3 Y	-6.45x
Revenue Growth5 Y	1.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.03
Assets	EUR 69.2M
Cash	EUR 2.6M
Current Assets	EUR 4.7M
Current Liabilities	EUR 77.8M
Debt	EUR 55.2M
Debt FCF	EUR -1.4
Equity	EUR -40.5M
Interest Coverage	-6.89
Liabilities	EUR 109.8M
Long Term Assets	EUR 64.6M
Long Term Liabilities	EUR 32M
Net Cash	EUR -52.6M
Net Cash By Market Cap	EUR -16.17
Tangible Book Value	EUR -97.2M
Tangible Book Value Per Share	EUR -0.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.06
Net Working Capital	EUR -39.8M
Quick ratio	0.03
Working Capital	EUR -73.4M
Working Capital Turnover	EUR -0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-26.83%
200-day SMA	0.21
3Y total return	-63.71%
50-day SMA	0.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-85%
All Time High	2.18
All Time High Change	-91.74%
All Time High Date	2020-10-20
All Time Low	0.11
All Time Low Change	65.14%
All Time Low Date	2017-06-14
ATR	0.03
Ch YTD	-12.62
High	0.2
High52	0.38
High52 Date	2026-01-30
High52ch	-52.63%
Low	0.18
Low52	0.11
Low52 Date	2026-03-09
Low52ch	63.64%
Ma50ch	0.73%
Price vs 200-day SMA	-12.58%
RSI	53.26
RSI Monthly	39.44
RSI Weekly	46.25
Sharpe ratio	0.46x
Sortino ratio	0.73
Total Return	-17.26%
Tr YTD	-12.62
Tr1m	2.86%
Tr3m	-21.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -51M
Operating margin	-4,347.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,606,992,404%
Net Borrowing	25,426,140.6
Shares Insiders	2.25%
Shares Institutions	0.06%
Shares Qo Q	2.9%
Shares Yo Y	17.26%
Short Ratio	23.88

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -40.4M
Average Volume	14,154.05x
Bv Per Share	-0.03
CAPEX	EUR -1.3M
Ch1m	2.86
Ch1y	-26.83
Ch3m	-21.74
Ch3y	-63.71
Ch5y	-85
Ch6m	-21.05
Change	0%
Change From Open	0
Close	0.18
Days Gap	0
Depreciation Amortization	1,750,193.6
Dollar Volume	270
Earnings Date	2026-05-13
EBIT	EUR -51M
EBITDA	EUR -49.3M
EPS	EUR -0.04
F Score	4
FCF	EUR -39.4M
FCF EV Yield	-10.14x
Financing CF	42,011,806
Fiscal Year End	December
Founded	1,996
Goodwill	530,824.2
Income Tax	EUR -457,363
Investing CF	-1,545,836
Is Primary Listing	0
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	0.2
Ma150ch	-10.85%
Ma20	0.17
Ma20ch	5.2%
Net CF	736,721
Next Earnings Date	2026-05-13
Open	0.18
Position In Range	0
Ppne	18,318,523.1
Price Date	2026-05-08
Relative Volume	0.11x
Revenue	1,173,643x
SBC By Revenue	87.59x
Share Based Comp	1,028,002
Tax By Revenue	-38.97x
Tr6m	-21.05%
Volume	1,500
Z Score	-27.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BST/NBYB pay a dividend?

Capital-return profile for this ticker.

Performance

BST/NBYB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BST/NBYB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+2.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BST/NBYB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.3

Neutral momentum band

Price vs 200-day MA

-12.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BST/NBYB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bst/NBYB stock rating?

bst/NBYB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bst/NBYB analysis?

The full report lives at /stocks/bst/NBYB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bst/NBYB?

The latest report frames bst/NBYB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bst/NBYB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.